Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Pulmonary Hypertension

  Free Subscription


1 Am J Physiol Lung Cell Mol Physiol
2 Am J Respir Crit Care Med
2 Ann Am Thorac Soc
1 Ann Thorac Surg
1 Arch Cardiol Mex
1 BMC Pulm Med
1 BMJ Open Respir Res
1 Circ Heart Fail
1 Cureus
1 Curr Opin Cardiol
1 Curr Opin Genet Dev
1 Curr Opin Pulm Med
1 Eur J Cardiothorac Surg
1 Eur Respir J
1 Front Cardiovasc Med
1 Front Immunol
1 Front Pediatr
1 G Ital Cardiol (Rome)
1 Heart Lung
1 Heart Lung Circ
1 Int J Gen Med
1 Int J Mol Sci
1 Intern Med J
1 J Bras Pneumol
2 J Heart Lung Transplant
1 J Pediatr
1 Mod Rheumatol Case Rep
1 Molecules
1 Neth Heart J
2 Oxid Med Cell Longev
1 Pulm Circ
1 Radiol Case Rep
2 Respir Res
1 Stem Cells Transl Med
1 Ther Adv Chronic Dis
1 Zhonghua Er Ke Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Physiol Lung Cell Mol Physiol

  1. LEE MH, Sanders L, Kumar R, Hernandez-Saavedra D, et al
    Contribution of Fatty Acid Oxidation to the Pathogenesis of Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2022 Jun 28. doi: 10.1152/ajplung.00039.2022
    PubMed         Abstract available

    Am J Respir Crit Care Med

  2. JANDL K, Marsh LM, Mutgan AC, Crnkovic S, et al
    Impairment of the NKT-STAT1-CXCL9-axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Due to Lung Fibrosis.
    Am J Respir Crit Care Med. 2022 Jun 28. doi: 10.1164/rccm.202201-0142.
    PubMed         Abstract available

  3. HERSI K, Elinoff JM
    Pulmonary Hypertension due to Interstitial Lung Disease: A New iNKlinig into Disease Pathobiology.
    Am J Respir Crit Care Med. 2022 Jun 30. doi: 10.1164/rccm.202206-1186.

    Ann Am Thorac Soc

  4. Erratum: Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
    Ann Am Thorac Soc. 2022;19:1243-1244.

  5. Erratum: Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
    Ann Am Thorac Soc. 2022;19:1242.

    Ann Thorac Surg

  6. CZAPLA J, Claus I, Martens T, Philipsen T, et al
    Midterm comparison between different annuloplasty techniques for functional tricuspid regurgitation.
    Ann Thorac Surg. 2021 Aug 25. pii: S0003-4975(21)01465.
    PubMed         Abstract available

    Arch Cardiol Mex

  7. RUEDA DA, Aguirre RA, Fonzo HD, Mazzei ME, et al
    Severe arterial pulmonary hypertension in a 34-year-old patient.
    Arch Cardiol Mex. 2022;92:418-419.

    BMC Pulm Med

  8. SUN X, Shi X, Cao Y, Zhu H, et al
    Variation of PetCO2 during incremental exercise and severity of IPAH and CTEPH.
    BMC Pulm Med. 2022;22:249.
    PubMed         Abstract available

    BMJ Open Respir Res

  9. CULLIVAN S, Lennon D, Meghani S, Minnock C, et al
    Incidence and outcomes of pulmonary hypertension in the Ireland.
    BMJ Open Respir Res. 2022;9.
    PubMed         Abstract available

    Circ Heart Fail

  10. PARK J, Banerjee S, Hong J, Umar S, et al
    Response by Park et al to Letter Regarding Article, "Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular
    Circ Heart Fail. 2022 Jun 29:101161CIRCHEARTFAILURE122008632.


  11. REHMAN A, Darira J, Ahmed MS, Hamid K, et al
    Evaluating Signs of Pulmonary Hypertension on Computed Tomography and Correlating With Echocardiography: A Study at a Tertiary Care Hospital.
    Cureus. 2022;14:e25319.
    PubMed         Abstract available

    Curr Opin Cardiol

  12. MICHAUD E, Pan M, Aggarwal V
    Catheter-based therapies in acute and chronic pulmonary embolism.
    Curr Opin Cardiol. 2021;36:704-710.
    PubMed         Abstract available

    Curr Opin Genet Dev

  13. TAHA F, Southgate L
    Molecular genetics of pulmonary hypertension in children.
    Curr Opin Genet Dev. 2022;75:101936.
    PubMed         Abstract available

    Curr Opin Pulm Med

  14. SEMEN KO, Bast A
    Senescence in pulmonary arterial hypertension: is there a link?
    Curr Opin Pulm Med. 2022;28:303-306.
    PubMed         Abstract available

    Eur J Cardiothorac Surg

  15. GOLOVENKO O, Lazorhyshynets V, Prokopovych L, Truba Y, et al
    Early and Long-term Results of Ventricular Septal Defect Repair in Children with Severe Pulmonary Hypertension and Elevated Pulmonary Vascular Resistance by Double or Traditional Patch Technique.
    Eur J Cardiothorac Surg. 2022 Jun 29. pii: 6619555. doi: 10.1093.
    PubMed         Abstract available

    Eur Respir J

  16. WESSELS JN, Mouratoglou SA, van Wezenbeek J, Handoko ML, et al
    Right atrial function is associated with right venticular diastolic stiffness: RA-RV interaction in pulmonary arterial hypertension.
    Eur Respir J. 2022;59.
    PubMed         Abstract available

    Front Cardiovasc Med

  17. RUBACKOVA POPELOVA J, Tomek J, Tomkova M, Zivna R, et al
    Normalization of Four Different Types of Pulmonary Hypertension After Atrial Septal Defect Closure.
    Front Cardiovasc Med. 2022;9:876755.
    PubMed         Abstract available

    Front Immunol

  18. TABELING C, Gonzalez Calera CR, Lienau J, Hoppner J, et al
    Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension.
    Front Immunol. 2022;13:895501.
    PubMed         Abstract available

    Front Pediatr

  19. BUFFONI I, Buratti S, Mallamaci MF, Pezzato S, et al
    Sudden Onset of Severe Pulmonary Hypertension in a Preterm Infant: A Case Report on the Role of Maternal Use of Serotonin Re-Uptake Inhibitors During Pregnancy and Concurrent Risk Factors.
    Front Pediatr. 2022;10:855419.
    PubMed         Abstract available

    G Ital Cardiol (Rome)

  20. CARAVITA S, Picariello C, Garascia A, Misuraca L, et al
    [Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab].
    G Ital Cardiol (Rome). 2022;23:533-541.
    PubMed         Abstract available

    Heart Lung

  21. JIANG Y, Hei B, Hao W, Lin S, et al
    Clinical value of lncRNA SOX2-OT in pulmonary arterial hypertension and its role in pulmonary artery smooth muscle cell proliferation, migration, apoptosis, and inflammatory.
    Heart Lung. 2022;55:16-23.
    PubMed         Abstract available

    Heart Lung Circ

  22. NI S, Ji T, Dong J, Chen F, et al
    Immune Cells in Pulmonary Arterial Hypertension.
    Heart Lung Circ. 2022;31:934-943.
    PubMed         Abstract available

    Int J Gen Med

  23. WANG N, Guo Z, Gong X, Kang S, et al
    A Nomogram for Predicting the Risk of Pulmonary Hypertension for Patients with Chronic Obstructive Pulmonary Disease.
    Int J Gen Med. 2022;15:5751-5762.
    PubMed         Abstract available

    Int J Mol Sci

  24. VAN UDEN D, Koudstaal T, van Hulst JAC, Vink M, et al
    Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity.
    Int J Mol Sci. 2022;23.
    PubMed         Abstract available

    Intern Med J

  25. NAING P, Kangaharan N, Scalia GM, Strange G, et al
    Pulmonary Hypertension in Remote and Disadvantaged Population: Overcoming Unique Challenges for Improved Outcomes.
    Intern Med J. 2022 Jun 28. doi: 10.1111/imj.15860.
    PubMed         Abstract available

    J Bras Pneumol

  26. FERNANDES CJCDS, Ota-Arakaki JS, Campos FTAF, Correa RA, et al
    Brazilian Thoracic Society recommendations for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension.
    J Bras Pneumol. 2022;46:e20200204.
    PubMed         Abstract available

    J Heart Lung Transplant

  27. HOEPER MM, Pausch C, Olsson KM, Huscher D, et al
    Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis.
    J Heart Lung Transplant. 2022;41:971-981.
    PubMed         Abstract available

  28. REDDY SA, Nethercott SL, Teh W, De Bie EM, et al
    Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;41:861-865.
    PubMed         Abstract available

    J Pediatr

  29. YANG EL, Levy PT, Critser PJ, Dukhovny D, et al
    The clinical and cost utility of cardiac catheterizations in infants with bronchopulmonary dysplasia.
    J Pediatr. 2022 Apr 14. pii: S0022-3476(22)00323.
    PubMed         Abstract available

    Mod Rheumatol Case Rep

  30. SAIKI C, Kashiwado Y, Yokoyama T, Ayano M, et al
    Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.
    Mod Rheumatol Case Rep. 2022;6:183-188.
    PubMed         Abstract available


  31. XU D, Hu YH, Gou X, Li FY, et al
    Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension.
    Molecules. 2022;27.
    PubMed         Abstract available

    Neth Heart J

  32. WOLTERS AEP, Wolters AJP, van Kraaij TDA, Kietselaer BLJH, et al
    Echocardiographic estimation of pulmonary hypertension in COVID-19 patients.
    Neth Heart J. 2022 Jun 30. pii: 10.1007/s12471-022-01702.
    PubMed         Abstract available

    Oxid Med Cell Longev

  33. CHANG S, Wu J, Jin J, Shi H, et al
    Aldehyde Dehydrogenase 2 (ALDH2) Elicits Protection against Pulmonary Hypertension via Inhibition of ERK1/2-Mediated Autophagy.
    Oxid Med Cell Longev. 2022;2022:2555476.
    PubMed         Abstract available

  34. BAO C, He Q, Wang H, Sun Y, et al
    Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models.
    Oxid Med Cell Longev. 2022;2022:2782429.
    PubMed         Abstract available

    Pulm Circ

  35. MALIGIREDDY AR, Shore S, Sreenivas Kumar A, Harikrishnan S, et al
    Current status and barriers in pulmonary hypertension care delivery in India: A qualitative analysis.
    Pulm Circ. 2022;12:e12094.
    PubMed         Abstract available

    Radiol Case Rep

  36. INOUE N, Morikawa S
    Unusual case of cerebral embolism after initiation of selexipag for sarcoidosis-related pulmonary hypertension: a case report.
    Radiol Case Rep. 2022;17:3009-3014.
    PubMed         Abstract available

    Respir Res

  37. SURAYA R, Nagano T, Ryanto GRT, Effendi WI, et al
    Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFkappaB inactivation.
    Respir Res. 2022;23:173.
    PubMed         Abstract available

  38. SCHIMMELPENNINK MC, Meek DB, Vorselaars ADM, Langezaal LCM, et al
    Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.
    Respir Res. 2022;23:169.
    PubMed         Abstract available

    Stem Cells Transl Med

  39. SHARMA M, Bellio MA, Benny M, Kulandavelu S, et al
    Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension.
    Stem Cells Transl Med. 2022 Jun 27. pii: 6618502. doi: 10.1093.
    PubMed         Abstract available

    Ther Adv Chronic Dis

  40. DUAN A, Li X, Jin Q, Zhang Y, et al
    Prognostic implication of noninvasive right ventricle-to-pulmonary artery coupling in chronic thromboembolic pulmonary hypertension.
    Ther Adv Chronic Dis. 2022;13:20406223221102803.
    PubMed         Abstract available

    Zhonghua Er Ke Za Zhi

  41. WANG CH, Chen JJ, Ge JJ, Ma XL, et al
    [Risk factors and short-term prognosis of early pulmonary hypertension in preterm infants].
    Zhonghua Er Ke Za Zhi. 2022;60:682-687.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.